20 Mar 2008 CHMP Upholds Negative Opinion for the EU Application for Cimzia® in the Treatment of Crohn's Disease
20 Mar 2008 Seattle Genetics Initiates SGN-33 Clinical Trial in Combination with Revlimid(R) for Myelodysplastic Syndromes (MDS)
20 Mar 2008 Zevalin(R) Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment
19 Mar 2008 MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
18 Mar 2008 Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
17 Mar 2008 Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
17 Mar 2008 MorphoSys Obtains Agreement for Production of Antibody Material in MOR202 Program with Crucell and DSM
16 Mar 2008 GlaxoSmithKline's Bosatria shows promise in late-stage study
13 Mar 2008 Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
13 Mar 2008 BioInvent signs deal with Bayer HealthCare for the discovery and development of therapeutic antibodies
12 Mar 2008 Amgen Statement on Successful Outcome of Romiplostim Panel Meeting
12 Mar 2008 Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
10 Mar 2008 iCo Therapeutics Provides iCo-008 Phase II Clinical Update
05 Mar 2008 Phase I/II Studies of IMC-A12 in Pediatric Cancer Patients Commence Enrollment
05 Mar 2008 Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
04 Mar 2008 UCB: Early Data on Cimzia(R) from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients
04 Mar 2008 Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
03 Mar 2008 BioWa Announces Expansion of License Agreement With Genetech for BioWa's POTELLIGENT(R) Technology
03 Mar 2008 Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
29 Feb 2008 Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer
27 Feb 2008 MorphoSys and Sigma-Aldrich Enter into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
27 Feb 2008 FDA Approves Regeneron's ARCALYST(TM) (rilonacept) for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
26 Feb 2008 Bradmer announces phase ii results published in newly diagnosed Glioblastoma which demonstrate improved survival and support upcoming Phase III study
25 Feb 2008 ESBATech's Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery Via Eye Drops
22 Feb 2008 FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up